ASH®-SAP

American Society of Hematology Self-Assessment Program

Ninth Edition

Date of release: June 2025

Date of expiration: Online access expiration and last date for learners to claim CME/MOC credit for this edition: June 30, 2028

Target Audience

ASH-SAP is a high-quality educational product offering up-to-date information in the field of hematology for hematologists, medical oncologists, internists, pediatricians, and hematology-oncology fellows and trainees.

CME Information

Of paramount importance to hematologists and others working in hematology-related fields is the need to stay current with the latest advances in the rapidly evolving disciplines of adult and pediatric hematology. The American Society of Hematology Self-Assessment Program (ASH-SAP) is the only complete, comprehensive educational resource available that fulfills this need while also providing thorough board and recertification preparation, as well as AMA PRA Category 1 Credit™ and lifelong learning points toward the American Board of Internal Medicine (ABIM) Maintenance of Certification program. ASH-SAP is designed for self-directed learning and review through utilization of a textbook with case studies, key points, and graphics. The activity is self-paced. Learners review and study the materials and then complete related multiple-choice questions in a separate question-and-answer book for self-assessment; the question-and-answer book also provides rationales for the answers for additional review and self-reflection. Extensive bibliographies are provided in the textbook as sources of information and for future reference. The ninth edition of ASH-SAP is available in a variety of reading and testing formats to best suit your learning and certification needs. All formats contain the following:

• Full-color text that contains the latest advancements in hematology
• Additional case studies within the text to further illustrate and emphasize the clinical applications of core knowledge
• Access to the companion website, which contains the information from the printed text but adds an interactive element, allowing users to move back and forth between questions and critiques, chapter text, and illustrative slides

The online material contains the full content of the printed book presented in a searchable format with hyperlinks to other educational resources, including Hematology, the ASH Education Program. Access to the online version is included with the purchase price of the print package. The printed question-and-answer book is included with the print package.

Educational Objectives

The goals of ASH-SAP are to provide timely clinical updates on new developments in hematology, to help practicing physicians prepare for recertification, and to serve as a tool for board review. Upon completion of the ninth edition of ASH-SAP, the learner will be able to achieve the following learning objectives, which correspond to the 6 online tests.

1. Laboratory Hematology and Cellular Therapy (6 credits)

a. Apply knowledge of laboratory testing to diagnose and monitor patients with hematologic disorders.

b. Develop an appropriate testing algorithm for patients with cytopenias.

c. Understand indications for hematopoietic stem cell therapy and potential complications.

2. Consultative Hematology (4 credits)

a. Apply diagnostic and management techniques for hematologic disorders in women.

b. Evaluate and treat hematologic complications of pregnancy.

c. Address common hematologic consultative questions relevant to surgical, solid organ transplant, and pediatric patients and hematologic complications of nonhematologic diseases.

3. Anemia, Iron Physiology, and Iron Disorders (9 credits)

a. Apply diagnostic and management strategies for patients with anemia.

b. Understand iron physiology and the pathophysiology, diagnosis, and management of iron disorders.

4. Thrombosis and Hemostasis (12 credits)

a. Evaluate and manage a patient with a bleeding diathesis using appropriate diagnostic testing and therapeutics.

b. Develop an appropriate diagnostic and management strategy for a patient with venous thromboembolism.

c. Understand the pathophysiology, clinical manifestations, and diagnosis of inherited and acquired platelet disorders.

5. Myeloid Diseases (7 credits)

a. Determine the most appropriate diagnostic strategy, including molecular testing, for a patient with a suspected or newly diagnosed myeloid disorder.

b. Understand and apply optimal risk-stratified therapy for myeloid neoplasms and congenital marrow failure syndromes.

6. Lymphoid Disorders (7 credits)

a. Evaluate a patient with a suspected lymphoid neoplasm using appropriate diagnostic studies.

b. Develop an appropriate management strategy for patients with newly diagnosed or relapsed lymphoid neoplasia.

Disclosures